404
+1-313-307-4176
Compounding Pharmacies Market Report
The Compounding Pharmacies Market is Segmented by Therapeutic Area Type (Hormone Replacement, Pain Management, Dermatology Applications, Specialty Drugs, Nutritional Supplements, and Others), by Product Type (Oral, Topical, Rectal, Parenteral, Nasal, Ophthalmic, and Optic ), by Application Type...
Covid-19 has impacted the market dynamics, competition, and global supply chain. The revenues have gone down in 2020 and may resume an uptrend gradually from 2021. Companies optimizing their operation and strategy will sustain and beat the competition.
Note: The summary below might not have included insights on covid impact since we have large number of reports.
Compounding pharmacies market is likely to witness a healthy CAGR of 5.8% during the forecast period. Growing geriatric population and improved life expectancy, increasing adoption of customized medicine in developed regions, advantages of compounded medication, and the increasing rate of drug failure are likely to drive the market in the coming years.
|
Compounding Pharmacies Market - Snapshot |
|
|
Growth |
5.8% for the next five years |
|
Major Therapeutic Area Type |
Hormone Replacement |
|
Dominant Product Type |
Parenteral |
|
Dominant Application Type |
Adult |
|
Faster-growing Sterility Type |
Non-sterile |
|
Major Distribution Channel Type |
Hospital Pharmacy |
|
Dominant Region |
Europe |
|
Key Players |
Athenex Inc., B. Braun Melsungen AG, Clinigen Group plc, Dougherty's Holdings, Inc., Fagron, Inc., Fresenius Kabi AG, Institutional Pharmacy Solutions, LLC, Lorraine’s Pharmacy, McGuff Company, Inc., and Pencol Compounding Pharmacy. |
Wish to Get a Free Sample? Register Here
Based on the therapeutic area type, the market is segmented as hormone replacement, pain management, dermatology applications, specialty drugs, nutritional supplements, and others. The hormone replacement segment is estimated to witness good growth due to the increasing hormonal imbalance in women.
Based on the product type, the market is segmented as oral, topical, rectal, parenteral, nasal, ophthalmic, and optic. The parenteral segment is likely to grow at the highest CAGR during the forecast period, as the increasing number of patients with different chronic conditions, including cancer and diabetes are opting for parenteral administration.
Based on the application type, compounding pharmacies market is segmented as pediatric, adult, geriatric, and veterinary. The adult segment would continue to dominate the market in the coming years as well, driven by the ability of compounding pharmacies to increase the ease of medication among adults which is facing difficulty in swallowing.
Based on the sterility type, compounding pharmacies market is segmented sterile and non-sterile. The non-sterile segment is likely to witness excellent growth in the coming years, driven by the increasing demand for non-sterile medication such as syrups, capsules, and pills.
Based on the distribution channel type, the market is segmented as hospital pharmacy, compounding pharmacy, and others. The hospital pharmacy segment dominated the market in 2019, driven by the surging hospital admissions.
In terms of regions, Europe is estimated to be the largest market, whereas Asia-Pacific would be the fastest-growing region for the compounding pharmacies market during the forecast period. Favorable reimbursement policies and the growing acceptance of compounding medication in Europe will foster the region’s overall growth. Also, technological advancements, presence of leading players, and well-established healthcare facilities will further contribute towards good growth of the market.
Know which region offers best growth opportuities. Register Here
Some of the major players in the compounding pharmacies market are-
In pharmacy, compounding is the creation of a particular pharmaceutical product to meet the unique needs of a particular patient. Compounded medications are made for specific patients. The conventional role of compounding pharmacies is to prepare drugs as prescribed by doctors for individual patients with needs that can't be met by the drugs that are commercially available.
This report studies the market covering a period of 12 years of trend and forecast. The report provides detailed insights into the market dynamics to enable informed business decision making and growth strategy formulation based on the opportunities present in the market.
|
Compounding Pharmacies Market Research Report - Features |
|
|
Market Segmentation |
7 |
|
Regions Covered |
4 |
|
Countries/Sub-Regions Covered |
17 |
|
No. of Figures & Tables |
>150 |
|
Company Profiles |
10 |
The compounding pharmacies market is segmented into the following categories.
This report offers high-quality insights and is the outcome of detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders and validation and triangulation with Stratview Research’s internal database and statistical tools. More than 1,000 authenticated secondary sources, such as company annual reports, fact book, press release, journals, investor presentation, white papers, patents, and articles have been leveraged to gather the data. We conducted more than 10 detailed primary interviews with the market players across the value chain in all four regions and with industry experts to obtain both the qualitative and quantitative insights.
This report provides market intelligence in the most comprehensive way. The report structure has been kept such that it offers maximum business value. It provides critical insights into the market dynamics and will enable strategic decision making for the existing market players as well as those willing to enter the market. The following are the key features of the report:
With this detailed report, Stratview Research offers one of the following free customization options to our respectable clients:
Company Profiling
Market Segmentation
Competitive Benchmarking
Custom Research: Stratview Research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry at [email protected].
The compounding pharmacies market is expected to witness an impressive growth of 5.8% CAGR in the foreseeable future.
Athenex Inc., B. Braun Melsungen AG, Clinigen Group plc, Dougherty's Holdings, Inc., Fagron, Inc., Fresenius Kabi AG, Institutional Pharmacy Solutions, LLC, Lorraine’s Pharmacy, McGuff Company, Inc., and Pencol Compounding Pharmacy are among the key players in the compounding pharmacies market.
Europe is expected to be the largest compounding pharmacies market during the next five years.
The adult segment is expected to remain dominant application type in the compounding pharmacies market in the coming years.
WE ACCEPT
